LVM Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.4M | Buy |
30,070
+157
| +0.5% | +$69.9K | 1.39% | 22 |
|
|
2025
Q1 | $14.5M | Sell |
29,913
-470
| -2% | -$228K | 1.61% | 18 |
|
|
2024
Q4 | $12.2M | Buy |
30,383
+370
| +1% | +$149K | 1.32% | 25 |
|
|
2024
Q3 | $14.1M | Hold |
30,013
| – | – | 1.6% | 20 |
|
|
2024
Q2 | $14.1M | Sell |
30,013
-402
| -1% | -$188K | 1.6% | 20 |
|
|
2024
Q1 | $12.7M | Buy |
30,415
+315
| +1% | +$132K | 1.5% | 24 |
|
|
2023
Q4 | $12.2M | Buy |
30,100
+45
| +0.1% | +$18.3K | 1.57% | 21 |
|
|
2023
Q3 | $10.5M | Buy |
30,055
+675
| +2% | +$235K | 1.47% | 23 |
|
|
2023
Q2 | $10.3M | Sell |
29,380
-1,150
| -4% | -$405K | 1.38% | 26 |
|
|
2023
Q1 | $9.62M | Sell |
30,530
-2,590
| -8% | -$816K | 1.33% | 29 |
|
|
2022
Q4 | $9.56M | Sell |
33,120
-1,240
| -4% | -$358K | 1.39% | 29 |
|
|
2022
Q3 | $9.95M | Sell |
34,360
-2,140
| -6% | -$620K | 1.52% | 25 |
|
|
2022
Q2 | $10.3M | Buy |
36,500
+3,384
| +10% | +$954K | 1.49% | 25 |
|
|
2022
Q1 | $8.64M | Buy |
33,116
+1,270
| +4% | +$331K | 1.14% | 33 |
|
|
2021
Q4 | $6.99M | Buy |
31,846
+321
| +1% | +$70.5K | 0.93% | 37 |
|
|
2021
Q3 | $5.72M | Buy |
31,525
+645
| +2% | +$117K | 0.86% | 37 |
|
|
2021
Q2 | $6.23M | Buy |
30,880
+1,695
| +6% | +$342K | 0.95% | 36 |
|
|
2021
Q1 | $6.27M | Buy |
29,185
+400
| +1% | +$86K | 1.02% | 33 |
|
|
2020
Q4 | $6.8M | Buy |
+28,785
| New | +$6.8M | 1.15% | 31 |
|